Jeffrey Paley is Director at Journey Medical Corp (DERM). They have made 6 open-market trades across 3 companies since 2014, most recently 2023-11-28.
CIK 0001595327
3 open-market purchases totalling $267K since 2018, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DERM | SELL | 2023-11-28 | 2023-11-29 | $5.22 | $9K | +42.7% | +35.2% | -4.7% |
| DERM | SELL | 2023-11-07 | 2023-12-08 | $3.51 | $9K | +25.5% | -10.8% | -42.3% |
| DERM | BUY | 2023-10-06 | 2023-10-10 | $2.98 | $45K | +8.3% | +22.7% | +78.7% |
| DERM | BUY | 2023-09-21 | 2023-09-25 | $2.97 | $89K | -3.4% | +12.4% | +138.8% |
| ATXI | BUY | 2018-12-03 | 2018-12-12 | $5.34 | $133K | +1.2% | +5.2% | +10.1% |
| RTRX | SELL | 2014-08-14 | 2014-08-18 | $12.28 | $246K | -9.6% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.